These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11363817)
1. Human growth hormone approved for wasting. James JS AIDS Treat News; 1996 Sep; (No 254):1-4. PubMed ID: 11363817 [TBL] [Abstract][Full Text] [Related]
2. AIDS activists secure approval for human growth hormone (Serostim). Crit Path AIDS Proj; 1996; (No 31):34. PubMed ID: 11363832 [TBL] [Abstract][Full Text] [Related]
3. Human growth hormone not recommended for approval on narrow advisory panel vote. James JS AIDS Treat News; 1996 Mar; (no 243):6-7. PubMed ID: 11363301 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone cut down at the pass. Gilden D GMHC Treat Issues; 1996 Mar; 10(3):6. PubMed ID: 11363391 [TBL] [Abstract][Full Text] [Related]
5. Wider access to human growth hormone. Baker R BETA; 1995 Sep; ():8, 10. PubMed ID: 11362898 [TBL] [Abstract][Full Text] [Related]
6. FDA approves human growth hormone for wasting syndrome. AIDS Patient Care STDS; 1996 Dec; 10(6):379-80. PubMed ID: 11361571 [No Abstract] [Full Text] [Related]
7. New drug to treat wasting syndrome. Common Factor; 1995 Apr; (no 10):19. PubMed ID: 11362344 [TBL] [Abstract][Full Text] [Related]
8. Slow launch for HGH. Gilden D GMHC Treat Issues; 1995 May; 9(5):1-3. PubMed ID: 11362410 [TBL] [Abstract][Full Text] [Related]
9. Human growth hormone - great promise at a price. Lein B PI Perspect; 1995 May; (no 16):17. PubMed ID: 11362425 [TBL] [Abstract][Full Text] [Related]
10. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment. Gelato M; McNurlan M; Freedland E Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071 [TBL] [Abstract][Full Text] [Related]
11. Wasting syndrome: oral oxandrolone re-released in U.S. James JS AIDS Treat News; 1995 Dec; (no 237):3-4. PubMed ID: 11363076 [TBL] [Abstract][Full Text] [Related]
12. Consensus statement on the further development of protease inhibitors and human growth hormone. AIDS Treat News; 1996 Mar; (no 243):8. PubMed ID: 11363302 [TBL] [Abstract][Full Text] [Related]
13. Highlights from the FDA antiviral drug advisory committee meetings, February 27-March 1, 1996. Baker R BETA; 1996 Mar; ():7-13. PubMed ID: 11363321 [TBL] [Abstract][Full Text] [Related]
14. Medi-Cal reimburses for growth hormone. AIDS Patient Care; 1995 Dec; 9(6):307. PubMed ID: 11361448 [No Abstract] [Full Text] [Related]
15. Human growth hormone available for AIDS wasting. Gilden D GMHC Treat Issues; 1995 Jan; 9(1):9-11. PubMed ID: 11367383 [TBL] [Abstract][Full Text] [Related]
17. Thalidomide for wasting syndrome: progress toward compromise. James JS AIDS Treat News; 1995 Nov; (no 234):1-5. PubMed ID: 11363041 [TBL] [Abstract][Full Text] [Related]
18. What you need to know about AIDS wasting. AIDS Alert; 1999 Apr; 14(4):suppl 1-2. PubMed ID: 11366222 [TBL] [Abstract][Full Text] [Related]
19. HCFA reverses ruling on AIDS wasting treatment. Health Care Financing Administration. AIDS Alert; 1999 Jun; 14(6):69. PubMed ID: 11366412 [TBL] [Abstract][Full Text] [Related]
20. Experts leery of new oral testosterone treatment. AIDS Alert; 1996 Jun; 11(6):66-7. PubMed ID: 11363543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]